Sloth Fever : Everything You Need to Know About the Deadly Virus Transmitted by Mosquitoes in the US and Europe

Sloth fever (Oropouche Virus): A Threat Beyond the Amazon

Over the years, the Oropouche virus (sloth fever) has found its way towards becoming a germ of public health importance, particularly in the Americas. This virus has been previously endemic in the Amazon, however, the Orthobunyavirus so no longer remains within its original geographical location. The virus has begun to move out of the Amazon which is now entering other geographical regions raising concern of health authorities across the world. And this year itself, the number of reports of the cases add up to over 8000 and with even reports of deaths being attributed to the virus, the urgency of knowing the Oropouche has never been more pronounced though.

What is the Oropouche Virus Infection—colloquially dubbed “sloth fever”?

The Oropouche virus (sloth fever) can be allocated to the Orthobunyavirus genus that causes Oropouche fever, and is spread through mosquitoes, in contrast with classic well known such as dengue – fever, Zika virus and chikungunya. Oropouche virus on the other hand is mainly transmitted with the midge Culicoides paraensis as the principal vector rather than mosquitoes as in the case of these viruses. This vector is distributed all over the American continent from the south USA to Argentina which makes the virus a possible risk to a very wide area.

The virus that was discovered in Trinidad and Tobago in 1955 wasfirst found in humans in Brazil more than 60 years ago. Up until a few years back, it had remained mostly endemic to the Amazons field, causing periodic epidemic outbursts. But recent development indicates there is widespread dissemination of the virus within the region, but also a large proportion of the population outside the Amazon are being affected for the first time.

Geographical Spread and Rising Concerns

According to data as of October 2023, the geographical coverage of Oropouche virus has expanded greatly after the year 2023. It has now progressed beyond the . It has most recently progressed to Africa with the countries of the United States, , Italy and Spain recording imported cases from travelers to endemic countries dominantly in South America.

In July, Brazilian authorities noted two deaths associated with the virus: a first since the discovery of the virus in the last seventy years. Difficulties recorded later necessitated changes in the information disseminated to the spokesmen towards the accurate portrayal of the ORP scientific approach. That month, the Organization of American States declared Oropouche as being of moderate risk level, which has to do with the ever present risk of the construction spreading. In the following month, the World Health Organization stated the virus to present a high regional risk, and thus invoked higher vigilance and other risks mitigating activity.

Symptoms of Oropouche virus infection—colloquially dubbed “sloth fever” and consideration in diagnosis

The clinical features presented by the Oropouche Virus are quite common with other arboviruses such as dengue and Zika. The signs and symptoms of this disease include all of the following:

• Fever
• Headache
• Body and joint aches
• Retrobular pain
• Nausea and vomiting

Due to these Non- specific presenting symptoms, the diagnosis of Oropouche fever based on clinical features alone is difficult. Laboratory specimens are warranted as the diagnosis of the disease cannot solely depend on clinical availability of the disease. The majority of the cases are mild and resolved within a week, severe complications like neurological and hemorrhagic complications are possible.

Has the Oropouche Virus (sloth fever) Grown In Fearful Proportions?

There are some studies which have suggested the Oropouche virus may be getting more virulent. In the month of July, two adult donor deaths were attributed to this virus, the first deaths reported as being related to Oropouche virus infection. Fetal deaths, congenital malformations have also been reported that could be attributed to the virus. For the first time in the world, it is noted that newborns with microcephaly carry antibodies to the Oropouche virus, which hints at the relationship between the virus and severe congenital complications. But, it is still necessary to explore this more to put things beyond doubt.

Vertical Transmission and Death Cases

One of the most distressing developments is that Oropouche virus (sloth fever) can be passed from an infected mother to the child. In surrogate case outlook, a woman with the viral infection was confirmed to be pregnant and later on the patient was diagnosed with fetal death. Several organs from the deceased fetus contained Oropouche viral RNA indicating that the virus has breached the placental membrane. Another report showed an opposite scenario in which the child was born alive, although died after a short while and the virus was found in the brain and other organs.

These cases, along with the two previously healthy women who developed severe denge-like symptoms and subsequently died, underscore Oropouche virus’s potential danger. Even though these cases have been the first to be recorded as case fatalities, the overall impact of the virus is still a mystery, thus further studies are warranted.

Why Should You Be Concerned?

There is therefore a cause for alarm with regards to the Oropouche virus (sloth fever) because it spreads quickly and causes severe disease and even death. Of importance is the geographical dispersion of the virus, particularly its invasiveness beyond the Amazon region to other parts of the world which poses the risk of outbreak in places where the midge Culicoides paraensis has immigrated. Additionally, because Oropouche fever has no vaccines or directed treatment, measures to control it focuse on prevention, detection of its outbreak and control of its spread after.

The spread of the Oropouche virus (sloth fever) equally brings into focus the more general problem of new emerging infectious disease. Increased travel and the effects of climate change are distributing previously localized diseases into regions which are now global threats. It is important to confront that Oropouche is one of the viruses but this cannot be the last goal because better understanding and management of the reasons of virus spreading is necessary for the prevention of future pandemics.

Preventive Measures and Future Outlook

Because there is no vaccine or specific antiviral treatment in place, preventive measures are necessary in the control of the Oropouche virus transmission. These include:

• Vector control: Taking Action to decrease the midges numbers through insecticides as well as through control of their habitats.
• Public awareness: Informing communities about the danger of the virus and how to shield themselves from it.
• Surveillance: Keep an eye on the virus transmission so as to quickly neutralize possible outbreaks.

Since the Oropouche virus has adopted geographical characteristics similar to those of the West Nile virus, means to effectively eradicate the threat will necessitate international efforts. For the virus, development of vaccines and drugs, and improvement of diagnostic techniques will alleviate the health problems due to this virus.

Under no circumstances should a person assume the Oropouche virus remains an enigma, never to be mastered by the outside world. The disease is rife against humanity as its further advance is rather feasible. Given the increasing range of the virus, the ways of its spreading, symptoms, and possible consequences treatment continue to be very important for the avoidance of more outbreaks. Response to this new health threat must involve public health practitioners, researchers, and the community members in order to safeguard the health of the world.

Also Read : Portugal Earthquake